Cargando…
Comprehensive molecular biomarker identification in breast cancer brain metastases
BACKGROUND: Breast cancer brain metastases (BCBM) develop in about 20–30% of breast cancer (BC) patients. BCBM are associated with dismal prognosis not at least due to lack of valuable molecular therapeutic targets. The aim of the study was to identify new molecular biomarkers and targets in BCBM by...
Autores principales: | Schulten, Hans-Juergen, Bangash, Mohammed, Karim, Sajjad, Dallol, Ashraf, Hussein, Deema, Merdad, Adnan, Al-Thoubaity, Fatma K., Al-Maghrabi, Jaudah, Jamal, Awatif, Al-Ghamdi, Fahad, Choudhry, Hani, Baeesa, Saleh S., Chaudhary, Adeel G., Al-Qahtani, Mohammed H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747948/ https://www.ncbi.nlm.nih.gov/pubmed/29287594 http://dx.doi.org/10.1186/s12967-017-1370-x |
Ejemplares similares
-
Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression
por: Schulten, Hans-Juergen, et al.
Publicado: (2016) -
Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines
por: Khan, Ishaq, et al.
Publicado: (2017) -
Initial characterization of drug resistant cancer stem cells isolated from primary brain tumors (astrocytoma) cell lines generated from Saudi patients
por: Khan, Ishaq, et al.
Publicado: (2014) -
Meta-analysis of whole-genome gene expression datasets assessing the effects of IDH1 and IDH2 mutations in isogenic disease models
por: Schulten, Hans-Juergen, et al.
Publicado: (2022) -
Brain and bone metastasis from malignant thyroid carcinomas originating in western Saudi Arabia
por: Baghallab, Ibtisam, et al.
Publicado: (2014)